[{"indications": "Indications\u00a0reduction of intra-ocular pressure in open-angle glaucoma, secondary\r\nglaucoma, and peri-operatively in angle-closure glaucoma; diuresis\r\n(section 2.2.7); epilepsy", "name": "ACETAZOLAMIDE Modified release", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.6 Treatment of glaucoma", "Carbonic anhydrase inhibitors and systemic drugs", "ACETAZOLAMIDE", "Modified release"], "cautions": "Cautions\u00a0not generally recommended for prolonged\r\nuse but if given monitor blood count and plasma-electrolyte\r\nconcentration; pulmonary obstruction and impaired alveolar ventilation (risk of acidosis); elderly; diabetes mellitus; renal calculi; avoid extravasation\r\nat injection site (risk of necrosis); interactions: Appendix 1 (diuretics)", "side-effects": "Side-effects\u00a0\n(From Carbonic anhydrase inhibitors and systemic drugs: British National Formulary)\nCarbonic anhydrase inhibitors and systemic drugs; also nausea,\r\nvomiting, diarrhoea, taste disturbance, loss of appetite, paraesthesia,\r\nflushing, headache, dizziness, fatigue, irritability, excitement,\r\nataxia, depression, thirst, polyuria, reduced libido; less\r\ncommonly melaena, drowsiness, confusion, hearing disturbances,\r\nfever, glycosuria, metabolic acidosis and electrolyte disturbances\r\non long-term therapy, haematuria, crystalluria, renal and ureteric\r\ncolic, renal lesions or calculi, renal failure, blood disorders, bone\r\nmarrow suppression, rash (including Stevens-Johnson syndrome and toxic\r\nepidermal necrosis); rarely fulminant hepatic necrosis,\r\nhepatitis, cholestatic jaundice, flaccid paralysis, convulsions, photosensitivity; also reported transient myopia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5521.htm", "doses": ["Glaucoma, by mouth or by intravenous injection, 0.25\u20131\u00a0g daily in divided\r\ndoses", "Epilepsy, by mouth or by intravenous injection, 0.25\u20131\u00a0g daily in divided doses; child 8\u201330\u00a0mg/kg daily, max. 750\u00a0mg daily", "Dose by intramuscular injection, as for intravenous injection but preferably avoided because of\r\nalkalinity", "Name[Diamox\u00ae SR (Goldshield) ] Capsules, m/r, orange, enclosing\r\norange f/c pellets, acetazolamide 250\u00a0mg. Net price\r\n30-cap pack = \u00a316.66 \r\n    Label:\r\n    3, 25Dose\u00a0glaucoma, 1\u20132 capsules daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid, especially in first trimester\r\n(toxicity in animal studies)"}, {"indications": "Indications\u00a0reduction of intra-ocular pressure in open-angle glaucoma, secondary\r\nglaucoma, and peri-operatively in angle-closure glaucoma; diuresis\r\n(section 2.2.7); epilepsy", "name": "ACETAZOLAMIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.6 Treatment of glaucoma", "Carbonic anhydrase inhibitors and systemic drugs", "ACETAZOLAMIDE"], "cautions": "Cautions\u00a0not generally recommended for prolonged\r\nuse but if given monitor blood count and plasma-electrolyte\r\nconcentration; pulmonary obstruction and impaired alveolar ventilation (risk of acidosis); elderly; diabetes mellitus; renal calculi; avoid extravasation\r\nat injection site (risk of necrosis); interactions: Appendix 1 (diuretics)", "side-effects": "Side-effects\u00a0\n(From Carbonic anhydrase inhibitors and systemic drugs: British National Formulary)\nCarbonic anhydrase inhibitors and systemic drugs; also nausea,\r\nvomiting, diarrhoea, taste disturbance, loss of appetite, paraesthesia,\r\nflushing, headache, dizziness, fatigue, irritability, excitement,\r\nataxia, depression, thirst, polyuria, reduced libido; less\r\ncommonly melaena, drowsiness, confusion, hearing disturbances,\r\nfever, glycosuria, metabolic acidosis and electrolyte disturbances\r\non long-term therapy, haematuria, crystalluria, renal and ureteric\r\ncolic, renal lesions or calculi, renal failure, blood disorders, bone\r\nmarrow suppression, rash (including Stevens-Johnson syndrome and toxic\r\nepidermal necrosis); rarely fulminant hepatic necrosis,\r\nhepatitis, cholestatic jaundice, flaccid paralysis, convulsions, photosensitivity; also reported transient myopia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5520.htm", "doses": ["Glaucoma, by mouth or by intravenous injection, 0.25\u20131\u00a0g daily in divided\r\ndoses", "Epilepsy, by mouth or by intravenous injection, 0.25\u20131\u00a0g daily in divided doses; child 8\u201330\u00a0mg/kg daily, max. 750\u00a0mg daily", "Dose by intramuscular injection, as for intravenous injection but preferably avoided because of\r\nalkalinity"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid, especially in first trimester\r\n(toxicity in animal studies)"}]